CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,792,000 | -50.4% | 210,257 | -70.6% | 3.39% | +46.2% |
| Q4 2018 | $5,625,000 | -44.1% | 714,764 | -21.3% | 2.32% | +20.2% |
| Q3 2018 | $10,068,000 | -9.5% | 908,664 | +9.7% | 1.93% | +12.0% |
| Q2 2018 | $11,121,000 | +0.4% | 828,655 | -2.8% | 1.72% | -5.6% |
| Q1 2018 | $11,076,000 | +124.4% | 852,686 | +58.9% | 1.82% | +100.4% |
| Q4 2017 | $4,936,000 | +3979.3% | 536,568 | +3477.1% | 0.91% | +2835.5% |
| Q3 2017 | $121,000 | – | 15,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |